Madras Fertilizers Ltd
MADRASFERTMadras Fertilizers Ltd's earnings have outrun its stock. EPS grew +25.1% in a year against a −28.6% price move.
The sharpest disagreement: annual EPS moved +25.1% against a −28.6% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (43 weeks in) while the P/E sits at the 49th percentile of its own 9-year range. Underneath, the last four quarters read improving, and 197% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Madras Fertilizers Ltd trades at ₹66.4, in a downtrend and 43 weeks into that stage. That is −8.1% against its own 200-day average. It sits at 27% of a 52-week range of ₹57 to ₹93. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (6 weeks and counting).
Today the stock is in a downtrend — week 43 of stage 4, confirmed. At ₹66.4 it trades −8.1% versus its 200-day average and sits at 27% of its 52-week range (₹57–₹93).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +445% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-06-25) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Madras Fertilizers Ltd trades at 12.3× P/E, mid-range by its own standards (49th percentile). Its long-run median P/E is 12.4×, measured across 9.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 12.3× is mid-range by its own standards (49th percentile), against a long-run median of 12.4× measured over 9.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +25.1% against a −28.6% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +15.3%/yr price move, ~+7.1%/yr came from earnings growth and ~+8.2 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Madras Fertilizers Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −9.5% | −12.6% | +8.5% | +6.7% |
| Profit | +25.0% | −24.4% | +92.8% | — |
| EPS | +25.1% | −24.3% | +94.3% | — |
| Share price | −28.6% | −5.8% | +15.3% | +15.7% |
4-Factor Sector Score
38.9/100 — rank 14 of 15 in Fertilisers · 62% evidence confidence
Madras Fertilizers Ltd scores 38.9 out of 100 against the 15 companies it is compared with in Fertilisers, ranking 14. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 13.5 + 10.3 + 10.2 + 4.9 = 38.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Madras Fertilizers Ltd reported ₹699 Cr of revenue in the Mar 26 quarter, +25.9% year on year. Over 10 years it has compounded at 6.7% a year. The last full year, FY26, came in at ₹2,300 Cr. The last four reported quarters add to ₹2,300 Cr.
FY26 revenue came in at ₹2,300 Cr (−9.5% on the year), capping 10 years at 6.7% compound. The latest quarter (Mar 26) printed ₹699 Cr, +25.9% year on year.
Pace check: the last four quarters averaged −5.8% growth against the decade's 6.7% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −9.5% over the last 4 quarters against +1.6%/yr over the last 8 — rolling over; TTM profit +24.6% vs +302.5%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Madras Fertilizers Ltd's operating margin is 5.0% in the Mar 26 quarter, +16.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −1.8% to 11.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 5.0%, +16.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −1.8%–11.0%.
Why the margin moved: operating margin went +16.2 pp year on year while gross margin went +4.9 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Madras Fertilizers Ltd earned ₹21.0 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹80.0 Cr. That is 3.0% of the quarter's revenue. The same quarter a year earlier lost ₹52.0 Cr. 3 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹21.0 Cr, null year on year. On the full year, FY26 printed ₹80.0 Cr (+25.0%).
Pace comparison, last four quarters: profit +154.7% vs revenue −5.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 197% of Madras Fertilizers Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹5.0 Cr of operating cash against ₹80.0 Cr of profit. After ₹30.0 Cr of capital spending, ₹−25.0 Cr was left as free cash.
FY26: operating cash of ₹5.0 Cr against reported profit of ₹80.0 Cr, leaving free cash of ₹−25.0 Cr after ₹30.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 197% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 197%: the cash cycle tightened 16 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: the bigger cash user is investment — capital spending ran 2.1× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Madras Fertilizers Ltd's cash conversion cycle runs 33 days in FY26, down from 49 days in FY21. Capital spending ran ₹74.0 Cr over the last 3 years. At FY26 sales of ₹2,300 Cr each day of that cycle holds about ₹6.3 Cr, so roughly ₹208 Cr sits inside the business at any moment.
FY26: debtors at 75 days, inventory at 47 days — roughly 1.5 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 33 days, tighter than FY21's 49.
The full loop: cash goes out to suppliers and production on day 0; stock waits 47 days to sell; customers pay about 75 days after that; and suppliers themselves are paid at 90 days — netting out to the 33-day cycle.
In money terms: at FY26 sales of ₹2,300 Cr, each day of the cycle holds about ₹6.3 Cr — so the 33-day loop keeps roughly ₹208 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹74.0 Cr over the last 3 fiscal years against ₹36.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹27.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Madras Fertilizers Ltd earns a ROCE of 15% in FY26. That is up from a trough of −5% in FY15. Return on invested capital clears the cost of that capital by +276.4 percentage points, so growth here adds value rather than only size. The wiring behind it is 3.5% net margin on 0.99× asset turns.
FY26 ROCE is 15%, recovered from a FY15 trough of −5% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 3.5% net margin × 0.99× asset turns × 25.36× balance-sheet leverage ≈ 87.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 288.4% − 12.0% = a +276.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Madras Fertilizers Ltd carries total debt of ₹634 Cr against shareholder equity of ₹92.0 Cr as of Mar 26, a debt-to-equity of 6.89. On the annual view that ratio went from −3.44 in FY22 to 6.89 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹634 Cr against shareholder equity of ₹92.0 Cr — a debt-to-equity of 6.89. On the annual view, debt-to-equity went from −3.44 (FY22) to 6.89 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Madras Fertilizers Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.0 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.0 points over 8 quarters to 85.3%; Foreign institutions: +0.0 points over 8 quarters to 0.0%; Domestic institutions: +0.0 points over 8 quarters to 0.1%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Madras Fertilizers Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gujarat Narmada Valley Fertilizers & Chemicals LtdGNFC | 69.5/100Favorable setup96% evidence | BREAKING OUT | 21.1/35 Revenue -1.5% · PAT 35.3% · OPM change 10 pp 88% evidence | 14.3/25 ROCE 12% · OPM 22% 100% evidence | 15.1/20 P/E 9.3× · PEG 0.27 100% evidence | 19.0/20 RS sector 11.8% · RS bench 3.1% · 1Y -5.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.1 + 14.3 + 15.1 + 19 = 69.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Krishana Phoschem LtdKRISHANA | 66.9/100Favorable setup100% evidence | BASING | 28.7/35 Revenue 73.3% · PAT 92.2% · OPM change 0 pp 100% evidence | 18.9/25 ROCE 27.2% · OPM 17% 100% evidence | 13.9/20 P/E 28.8× · PEG 0.58 100% evidence | 5.4/20 RS sector -54.9% · RS bench 56.5% · 1Y -65.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 28.7 + 18.9 + 13.9 + 5.4 = 66.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -54.9% and the one-year return is -65.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Chambal Fertilisers & Chemicals LtdCHAMBLFERT | 66.3/100Favorable setup100% evidence | ASLEEP | 17.1/35 Revenue 15.6% · PAT 10.2% · OPM change 3 pp 100% evidence | 18.9/25 ROCE 25.5% · OPM 16% 100% evidence | 17.0/20 P/E 9.1× · PEG 0.52 100% evidence | 13.3/20 RS sector 0.4% · RS bench -7.8% · 1Y -18.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 18.9 + 17 + 13.3 = 66.3 · Decision use: Price leads the evidence: RS versus the benchmark is -7.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Rashtriya Chemicals & Fertilizers LtdRCF | 51.2/100Mixed-positive evidence90% evidence | ASLEEP | 21.9/35 Revenue 9.1% · PAT 76.5% · OPM change 1.2 pp 88% evidence | 7.5/25 ROCE 10.2% · OPM 6% 100% evidence | 12.6/20 P/E 17.8× · PEG 0.9 100% evidence | 9.2/20 RS sector -3.1% · RS bench -7.8% · 1Y -16.7%3 of 10 weeks ahead 70% evidence |
| Exact sum: 21.9 + 7.5 + 12.6 + 9.2 = 51.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Khaitan Chemicals & Fertilizers LtdKHAICHEM | 51.1/100Mixed-positive evidence74% evidence | 20.6/35 Revenue 19.9% · PAT 32.5% · OPM change -3 pp 95% evidence | 15.6/25 ROCE 18.5% · OPM 11% 95% evidence | 11.1/20 P/E 8.2× · PEG — 15% evidence | 3.8/20 RS sector -31.3% · RS bench -38.4% · 1Y -57.1%1 of 8 weeks ahead 70% evidence | |
| Exact sum: 20.6 + 15.6 + 11.1 + 3.8 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Paradeep Phosphates LtdPARADEEP | 51.1/100Mixed-positive evidence69% evidence | TURNING | 19.4/35 Revenue 28.1% · PAT 12.6% · OPM change -1 pp 95% evidence | 14.3/25 ROCE 17.1% · OPM 12% 76% evidence | 10.0/20 P/E 14.1× · PEG — 15% evidence | 7.4/20 RS sector -12.4% · RS bench -2.6% · 1Y -22.2%6 of 10 weeks ahead 70% evidence |
| Exact sum: 19.4 + 14.3 + 10 + 7.4 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Madhya Bharat Agro Products LtdMBAPL | 50.3/100Mixed-positive evidence100% evidence | BASING | 24.3/35 Revenue 47.6% · PAT 100% · OPM change 2 pp 100% evidence | 16.1/25 ROCE 19.3% · OPM 16% 100% evidence | 4.5/20 P/E 45.3× · PEG 2.04 100% evidence | 5.4/20 RS sector -52.8% · RS bench 63.9% · 1Y -62.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.3 + 16.1 + 4.5 + 5.4 = 50.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -52.8% and the one-year return is -62.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Southern Petrochemicals Industries Corporation LtdSPIC | 49.6/100Mixed-negative evidence76% evidence | ASLEEP | 17.5/35 Revenue -4.2% · PAT 36.1% · OPM change 3.1 pp 83% evidence | 14.3/25 ROCE 17.5% · OPM 8% 95% evidence | 11.3/20 P/E 6.4× · PEG — 15% evidence | 6.5/20 RS sector -8.2% · RS bench -16.4% · 1Y -32.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 14.3 + 11.3 + 6.5 = 49.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Zuari Agro Chemicals LtdZUARI | 47.9/100Mixed-negative evidence81% evidence | ASLEEP | 15.9/35 Revenue -44% · PAT 100% · OPM change -1 pp 95% evidence | 9.9/25 ROCE 16.4% · OPM 10% 95% evidence | 14.6/20 P/E 3.2× · PEG — 50% evidence | 7.5/20 RS sector -6.9% · RS bench -10.8% · 1Y 9.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 15.9 + 9.9 + 14.6 + 7.5 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Gujarat State Fertilizers & Chemicals LtdGSFC | 46.8/100Mixed-negative evidence90% evidence | ASLEEP | 17.3/35 Revenue 14.8% · PAT 13.9% · OPM change -1 pp 88% evidence | 6.7/25 ROCE 7.2% · OPM 3.2% 100% evidence | 15.1/20 P/E 9.4× · PEG 0.3 100% evidence | 7.7/20 RS sector -5.5% · RS bench -11.8% · 1Y -21%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.3 + 6.7 + 15.1 + 7.7 = 46.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Deepak Fertilisers & Petrochemicals Corp LtdDEEPAKFERT | 45.9/100Mixed-negative evidence94% evidence | TURNING | 13.3/35 Revenue 13.6% · PAT -0.5% · OPM change 7 pp 100% evidence | 11.8/25 ROCE 11.6% · OPM 26% 100% evidence | 11.2/20 P/E 19.9× · PEG 0.52 100% evidence | 9.6/20 RS sector -11.5% · RS bench 15.9% · 1Y 1.2%10 of 10 weeks ahead 70% evidence |
| Exact sum: 13.3 + 11.8 + 11.2 + 9.6 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Coromandel International LtdCOROMANDEL | 44.8/100Mixed-negative evidence94% evidence | TURNING | 12.7/35 Revenue 23.5% · PAT -20.9% · OPM change -2 pp 100% evidence | 16.9/25 ROCE 22% · OPM 9% 100% evidence | 1.5/20 P/E 32.8× · PEG 2.69 100% evidence | 13.7/20 RS sector 5% · RS bench -4.6% · 1Y -15.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.7 + 16.9 + 1.5 + 13.7 = 44.8 · Decision use: Price leads the evidence: RS versus the benchmark is -4.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13National Fertilizer LtdNFL | 41.7/100Mixed-negative evidence89% evidence | ASLEEP | 19.3/35 Revenue 8.7% · PAT 15.2% · OPM change 2 pp 88% evidence | 6.1/25 ROCE 9.1% · OPM 7% 100% evidence | 10.1/20 P/E 16.6× · PEG 1.39 65% evidence | 6.2/20 RS sector -6.9% · RS bench -14.8% · 1Y -27.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 6.1 + 10.1 + 6.2 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Madras Fertilizers Ltdthis pageMADRASFERT | 38.9/100Mixed-negative evidence62% evidence | ASLEEP | 13.5/35 Revenue -9.5% · PAT 24.6% · OPM change 16 pp 62% evidence | 10.3/25 ROCE 14.8% · OPM 5% 95% evidence | 10.2/20 P/E 12.3× · PEG — 15% evidence | 4.9/20 RS sector -14.4% · RS bench -12.3% · 1Y -25.5%3 of 10 weeks ahead 70% evidence |
| Exact sum: 13.5 + 10.3 + 10.2 + 4.9 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Fertilizers & Chemicals Travancore LtdFACT | 37.0/100Mixed-negative evidence89% evidence | ASLEEP | 17.5/35 Revenue 30.4% · PAT 100% · OPM change -5.6 pp 88% evidence | 4.2/25 ROCE 8.7% · OPM 2.4% 100% evidence | 5.0/20 P/E 3612× · PEG 2.49 65% evidence | 10.3/20 RS sector 1.8% · RS bench -6.4% · 1Y -13.7%5 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 4.2 + 5 + 10.3 = 37 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Madras Fertilizers Ltd's share price today?
Madras Fertilizers Ltd trades at ₹66.4, −28.6% over the past year. The company is valued at ₹1,070 Cr. The stock sits at 27% of its 52-week range of ₹57–₹93, −8.1% versus its 200-day average. On the tape, the price is in a downtrend, 43 weeks in. — as of 31 July 2026.
What were Madras Fertilizers Ltd's latest quarterly results?
Madras Fertilizers Ltd reported revenue of ₹699 Cr and net profit of ₹21.0 Cr for the Mar 26 quarter. Earnings per share were ₹1.30. The operating margin was 5.0%, 16.0 pp higher than a year earlier. — as of 31 July 2026.
What is Madras Fertilizers Ltd's revenue?
Madras Fertilizers Ltd reported revenue of ₹699 Cr in the Mar 26 quarter, +25.9% year on year. For the full FY26 fiscal year, revenue was ₹2,300 Cr (−9.5%). Over the last 10 years revenue compounded at 6.7% a year. — as of 31 July 2026.
What is Madras Fertilizers Ltd's profit?
Madras Fertilizers Ltd earned ₹21.0 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹80.0 Cr. The operating margin ran 5.0% in the latest quarter. — as of 31 July 2026.
What is Madras Fertilizers Ltd's market cap?
Madras Fertilizers Ltd's market capitalisation is ₹1,070 Cr at a share price of ₹66.4. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Madras Fertilizers Ltd's P/E ratio?
Madras Fertilizers Ltd trades at a P/E of 12.3×, at the 49th percentile of its own 9-year range, against a long-run median of 12.4×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Madras Fertilizers Ltd pay a dividend?
No — Madras Fertilizers Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Madras Fertilizers Ltd overvalued?
On its own history, Madras Fertilizers Ltd looks mid-range against its own history: its P/E of 12.3× sits at the 49th percentile of its 9-year range (long-run median 12.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
How is Madras Fertilizers Ltd performing?
Madras Fertilizers Ltd is in a downtrend, 43 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Madras Fertilizers Ltd in an uptrend?
No — the price is in a downtrend (week 43 of stage 4), trading −8.1% versus its 200-day average and at 27% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Madras Fertilizers Ltd beating the market?
Not lately — on a trailing-13-week view Madras Fertilizers Ltd is currently behind the NIFTY 500 (6 weeks and counting; last ahead the week of 2026-06-25), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +445% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Madras Fertilizers Ltd's share price go up?
This page publishes no price forecast for Madras Fertilizers Ltd. What it measures instead: the share price is ₹66.4, the price is in a downtrend 43 weeks in. Its P/E of 12.3× sits at the 49th percentile of its own 9-year range. — as of 31 July 2026.
Who owns Madras Fertilizers Ltd?
Promoters hold 85.3% of Madras Fertilizers Ltd, foreign institutions 0.0%, domestic institutions 0.1% and the public 14.7% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.
Does Madras Fertilizers Ltd have too much debt?
It carries real leverage — Madras Fertilizers Ltd's debt-to-equity is 6.89, and operating profit covers the interest bill 2×. FY26 borrowings were ₹634 Cr against equity of ₹92.0 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Madras Fertilizers Ltd's capex?
Madras Fertilizers Ltd spent ₹74.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹30.0 Cr, with ₹27.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Madras Fertilizers Ltd's cash flow?
Madras Fertilizers Ltd generated ₹5.0 Cr of operating cash flow in FY26 and ₹−25.0 Cr of free cash flow after ₹30.0 Cr of capital spending. Reported profit that year was ₹80.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Madras Fertilizers Ltd's profit real cash?
Yes — over the last 3 fiscal years, 197% of Madras Fertilizers Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹5.0 Cr against reported profit of ₹80.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Madras Fertilizers Ltd in its business cycle?
Madras Fertilizers Ltd's FY26 operating margin was 4.8%, against a 13-year band of −1.8%–11.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 5.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Madras Fertilizers Ltd story?
The sharpest disagreement: annual EPS moved +25.1% against a −28.6% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Madras Fertilizers Ltd a stock worth studying right now?
This is not investment advice. The machine read: Madras Fertilizers Ltd's earnings have outrun its stock. EPS grew +25.1% in a year against a −28.6% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.